Rutgers-New Jersey Medical School is a clinical research site located in Newark, New Jersey, United States 07103.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Rutgers-New Jersey Medical School has participated in 8 clinical trials with 2 currently active.
Therapeutic areas: Alcohol Associated Hepatitis, Acute-On-Chronic Liver Failure, Alcoholic Hepatitis.
Sponsors: Intercept Pharmaceuticals, Grifols Therapeutics LLC, Durect.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rutgers-New Jersey Medical School has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rutgers-New Jersey Medical School has 8 clinical trials on record, with 2 currently active. Their work covers Alcohol Associated Hepatitis, Acute-On-Chronic Liver Failure, Alcoholic Hepatitis.
Yes — Rutgers-New Jersey Medical School holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.